Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/18/2014 | WO2014142705A1 A cytokine-containing drug having an antiviral, antimicrobial, immunomodulatory and anti-inflammatory effect for treating and prophylaxis of infectious diseases |
09/18/2014 | WO2014142356A1 Therapeutic agent for scleroderma |
09/18/2014 | WO2014142102A1 Liquid aqueous composition |
09/18/2014 | WO2014141877A1 Tissue repair material |
09/18/2014 | WO2014141683A1 Kntc2 peptides and vaccines containing the same |
09/18/2014 | WO2014141652A1 Smyd3 peptides and vaccines containing the same |
09/18/2014 | WO2014141244A1 Synthetic peptides for the treatment of autoimmune diseases |
09/18/2014 | WO2014141165A1 Use of insulin signaling antagonists, optionally in combination of transfection of non-beta cells, for inducing insulin production |
09/18/2014 | WO2014141149A1 Formulations with reduced viscosity |
09/18/2014 | WO2014141124A1 Erk-pathway activating compound for preventing or treating leptin resistance |
09/18/2014 | WO2014141121A1 Composition containing digestive enzymes and nutrients suitable for enteral administration |
09/18/2014 | WO2014140504A1 Bone substitutes grafted by mimetic peptides of human bmp-2 protein |
09/18/2014 | WO2014140391A1 Use of garvicin a as an antimicrobial product |
09/18/2014 | WO2014140284A1 Use of linagliptin in cardio- and renoprotective antidiabetic therapy |
09/18/2014 | WO2014139894A1 Homoarginine as therapeutic for the reduction of myocardial remodeling |
09/18/2014 | WO2014139809A1 Method and kit for producing biomaterial for tissue regeneration |
09/18/2014 | WO2014139472A1 Compositions and methods of using islet neogenesis peptides and analogs thereof |
09/18/2014 | WO2014139468A1 Fusion protein molecules and method of use |
09/18/2014 | WO2014139329A1 Spray-dried powder comprising vancomycin hydrochloride, and industrial manufacturing method thereof |
09/18/2014 | WO2014139227A1 Lump sugar, and production method and application thereof |
09/18/2014 | WO2014139182A1 Compositions and methods of using islet neogenesis peptides and analogs thereof |
09/18/2014 | WO2014139168A1 Preparation process of polymeric microspheres |
09/18/2014 | WO2014139014A1 Methods and compositions for the inhibition of vascular endothelial growth factor activity and vascular permeability |
09/18/2014 | WO2014139008A1 Small molecule modulators of pcsk9 and methods of use thereof |
09/18/2014 | WO2014138953A1 Treatment of endometriosis, angiogenesis and/or endometrial lesion growth |
09/18/2014 | WO2014138927A1 Treatment of gluten intolerance and related conditions |
09/18/2014 | WO2014138921A1 Enhanced liquid formulation stability of erythropoietin alpha through purification processing |
09/18/2014 | WO2014138819A1 Agents that neutralize il-3 signaling and uses thereof |
09/18/2014 | WO2014138796A1 Dosage regimen for therapeutic method |
09/18/2014 | US20140276493 Wound healing compositions |
09/18/2014 | US20140275904 Sensors, Sensor Systems and Methods |
09/18/2014 | US20140275479 Specific binding agents of human angiopoeitin-2 |
09/18/2014 | US20140275230 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
09/18/2014 | US20140275226 Method of controlling coagulation |
09/18/2014 | US20140275225 Modulators of pharmacological agents |
09/18/2014 | US20140275212 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
09/18/2014 | US20140274915 Methods of Use for Recombinant Human Secretoglobins |
09/18/2014 | US20140274905 Methods and compounds for calcium ion channel regulation |
09/18/2014 | US20140274902 Recombinant fviii formulations |
09/18/2014 | US20140274900 Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
09/18/2014 | US20140274899 Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same |
09/18/2014 | US20140274898 Hair growth methods using fgfr3 extracellular domains |
09/18/2014 | US20140274897 Method for preventing and treating diabetes using neurturin |
09/18/2014 | US20140274895 Methods And Non-Immunogenic Compositions For Treating Inflammatory Disorders |
09/18/2014 | US20140274894 Methods for making cytokine compositions from tissues using non-centrifugal methods |
09/18/2014 | US20140274893 Methods and Acellular Compositions For Treating Inflammatory Disorders |
09/18/2014 | US20140274892 Reducing the risk of autoimmune disease |
09/18/2014 | US20140274891 Method of generating an index score for mbl deficiency to predict cardiodiabetes risk |
09/18/2014 | US20140274886 Methods and systems for adjusting rumen undegraded protein in animal diets |
09/18/2014 | US20140274883 Novel antiviral compounds from marine extracts |
09/18/2014 | US20140274881 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
09/18/2014 | US20140274879 Methods of use for an antimicrobial peptide |
09/18/2014 | US20140274873 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process |
09/18/2014 | US20140273204 Method Of Producing A Paralytic Peptide |
09/18/2014 | US20140271938 Systems and methods for delivery of peptides |
09/18/2014 | US20140271937 Brain and neural treatments comprising peptides and other compositions |
09/18/2014 | US20140271936 Memory or learning using peptide and other compositions |
09/18/2014 | US20140271935 Methods and systems for treating or preventing cancer |
09/18/2014 | US20140271934 Peptide systems and methods for metabolic conditions |
09/18/2014 | US20140271926 Methods of use of glutamine synthetase inhibitors |
09/18/2014 | US20140271923 Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
09/18/2014 | US20140271914 Bone graft materials containing calcium phosphate and chitosan |
09/18/2014 | US20140271902 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
09/18/2014 | US20140271901 Management of Tractional Membranes |
09/18/2014 | US20140271897 Compositions, methods and devices for local drug delivery |
09/18/2014 | US20140271888 Diketopiperazine microparticles with defined specific surface areas |
09/18/2014 | US20140271886 Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents |
09/18/2014 | US20140271870 Treatment of pain using protein solutions |
09/18/2014 | US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells |
09/18/2014 | US20140271861 Matrix compositions for controlled release of peptide and polypeptide molecules |
09/18/2014 | US20140271855 Sovaprevir tablets |
09/18/2014 | US20140271824 Acid Stable Liposomal Compositions And Methods For Producing The Same |
09/18/2014 | US20140271811 Topical systems and methods for treating sexual dysfunction |
09/18/2014 | US20140271808 Systems and methods for delivery of peptides |
09/18/2014 | US20140271807 Brain and neural treatments comprising peptides and other compositions |
09/18/2014 | US20140271806 Memory or learning using peptide and other compositions |
09/18/2014 | US20140271805 Compositions and methods for affecting mood states |
09/18/2014 | US20140271804 Methods and systems for treating or preventing cancer |
09/18/2014 | US20140271803 Peptide systems and methods for metabolic conditions |
09/18/2014 | US20140271802 Wound healing using topical systems and methods |
09/18/2014 | US20140271801 Cardiovascular disease treatment and prevention |
09/18/2014 | US20140271764 Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents |
09/18/2014 | US20140271735 Use of calcitonin in osteoarthritis |
09/18/2014 | US20140271732 Wound healing using topical systems and methods |
09/18/2014 | US20140271731 Cardiovascular disease treatment and prevention |
09/18/2014 | US20140271730 Immune modulation using peptides and other compositions |
09/18/2014 | US20140271724 Methods and compositions for treating or preventing cancer |
09/18/2014 | US20140271695 Immunogenic lhrh compositions and methods relating thereto |
09/18/2014 | US20140271684 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
09/18/2014 | US20140271668 Increasing parkin activity by administering a deubiquitinating enzyme inhibitor |
09/18/2014 | US20140271660 Monoclonal antibodies against antithrombin beta |
09/18/2014 | US20140271645 Method for treating inflammation |
09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
09/18/2014 | US20140271625 Methods for treating bleeding disorders |
09/18/2014 | US20140271613 Surgical Compositions |
09/18/2014 | US20140271612 Treatment Method and Product for Uterine Fibroids using Purified Collagenase |
09/18/2014 | US20140271609 In vivo temporal control of activatable matrix-degrading enzymes |
09/18/2014 | US20140271608 Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins |
09/18/2014 | US20140271607 Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof |
09/18/2014 | US20140271606 Methods of using adenosine receptor antagonists for treating bleeding disorders |